drugset / Trial / NCT01695616

Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms

NCT01695616

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effects of Passiflora incarnata and Isoflavone combination in relieving the symptoms associated with Climacteric Syndrome.

Timeline

Start
2013-08
Primary completion
2014-08
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Isoflavone Small molecule Oral
Comparator Passiflora incarnata Unknown Oral

Indications

No indication recorded.